Osteoarthritis Synovial Fluid

All filters

Format

Format

Format
Volume

Volume

Volume
Condition

Condition

Condition

Start typing to see matching condition.

Most stocked

Donor Demographics

Donor Demographics

Gender
Age
Race

Start typing to see matching race.

Country
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot # / SO#

Start typing to see matching Lot # / SO#.

Patient ID

Start typing to see matching Patient ID.

7 lots match
7 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Osteoarthritis Synovial Fluid 76378 149323 Male 31-45 Caucasian African American Cryopreserved, Fresh, Frozen 1 mL 16 — Cymbalta 60mg 1x a day Skyrizi 150mg every 3 months for (PSA) Psoriatic Arthritis, Osteoarthritis United States 2026 02:20:01G/24:02:01G 08:01:01G 07:01:01G 03:01:01G — 05:01:01G 02:01:01G 01:03:01G/01:04:01G 04:01:01G/15:01:01G 201465; 201464; 201463; 201462; 201461; 201460; 201459; 201458; 201457; 201456; 201454; 201453; 201452; 201451; 201450; 201455Synovial Fluid1.0OsteoarthritisOsteoarthritis;Psoriatic ArthritisNo22.89Non ReactiveYesYesNoNoNoNOYesORH+StoredIn Stock
$750
Osteoarthritis Synovial Fluid 82143 149323 Male 31-45 Caucasian African American Cryopreserved, Fresh, Frozen 1 mL 20 — Cymbalta 60mg 1x a day Skyrizi 150mg every 3 months for (PSA) Osteoarthritis United States 2026 02:20:01G/24:02:01G 08:01:01G 07:01:01G 03:01:01G — 05:01:01G 02:01:01G 01:03:01G/01:04:01G 04:01:01G/15:01:01G 276575; 276574; 276570; 276561; 276573; 276571; 276569; 276568; 276566; 276562; 276572; 276567; 276564; 276559; 276560; 276565; 276557; 276563; 276556; 276558Synovial Fluid1.0OsteoarthritisOsteoarthritisNo22.89Non ReactiveYesYesNoNoNoNOYesORH+StoredIn Stock
$750
Osteoarthritis Synovial Fluid 82279 147537 Female 61+ Caucasian Cryopreserved, Fresh, Frozen 1 mL 8 — Multivitamin Osteoarthritis United States 2026 01:01:01:01/11:01:01:01 — — — — — — — — 276549; 276548; 276547; 276544; 276546; 276545; 276543; 276542Synovial Fluid1.0OsteoarthritisOsteoarthritis;HealthyYesPollen; Ragweed25.05ReactiveYesYesNoNoNoNOYesORH+StoredIn Stock
$750
Osteoarthritis Synovial Fluid 82096 119278 Female 61+ African American Cryopreserved, Fresh, Frozen 1 mL 7 — amlodipine/ 10mg/ QD/ hydrochlorothiazide/ 25mg/QD lovastatin/ 20mg/ QD Osteoarthritis United States 2026 — — — — — — — — — 275080; 275081; 275079; 275078; 275077; 275076; 275075Synovial Fluid1.0OsteoarthritisOsteoarthritis;HealthyNoseasonal36.49NoNoNoNoNoNOYesStoredIn Stock
$750
Osteoarthritis Synovial Fluid 80513 147537 Female 61+ Caucasian Cryopreserved, Fresh, Frozen 1 mL 5 — Multivitamin Osteoarthritis United States 2026 01:01:01:01/11:01:01:01 — — — — — — — — 271434; 271437; 271436; 271435; 271433Synovial Fluid1.0OsteoarthritisOsteoarthritis;HealthyYesPollen; Ragweed25.05ReactiveYesYesNoNoNoNOYesORH+StoredIn Stock
$750
Osteoarthritis Synovial Fluid 76376 141573 Female 46-60 African American Cryopreserved, Fresh, Frozen 1 mL 1 — Benlysta Injection once week Hydroxychloroquine 200mg qd Methotrexate 25mg Mondays Folic Acid ydrochlorothiazide 25 qd Gabapentin 300mg qd Vitamin D3 200mg qd Zyrtec Inhaler Fluticasone 50mcg bid Osteoarthritis United States 2026 — — — — — — — — — 201467Synovial Fluid1.0OsteoarthritisOsteoarthritisYesPenicillin and Seasonal allergies31.56ReactiveYesNoYesTuberculosisNoYesNOYesStoredIn Stock
$750
Osteoarthritis Synovial Fluid 76382 143856 Male 61+ Caucasian Cryopreserved, Fresh, Frozen 1 mL 1 — Losartan Rinvoq // 30 mg // QD Osteoarthritis United States 2026 02:01:01G/03:01:01G 07:02:01G 07:02:01G 13:01:01G/15:01:01G — 01:02:01G/01:03:01G 06:02:01G/06:03:01G 01:03:01G 02:01:02G/04:01:01G 201555Synovial Fluid1.0OsteoarthritisOsteoarthritisNo32.98Non ReactiveYesNoNoNoNoNOYesARH+StoredIn Stock
$750

Showing 1–7 of 7 lots

About Osteoarthritis Synovial Fluid

Osteoarthritis Synovial Fluid is sourced from consented donors with documented osteoarthritis. These samples support joint and inflammation research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Osteoarthritis research
  • Joint inflammation research
  • Synovial fluid proteomic studies
  • Soluble-protein studies
  • Research assay development

Product Features

  • Human synovial fluid
  • Donor condition: Osteoarthritis
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Donor and clinical data in these lots

Fields recorded on the 7 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.

Donor

Sex
7 of 7 lots
Age
7 of 7 lots
Race
7 of 7 lots
BMI
7 of 7 lots

Clinical history

Primary diagnosis
7 of 7 lots
Current medications
7 of 7 lots
Comorbidities
1 of 7 lots
Allergies
7 of 7 lots
Infectious disease history
7 of 7 lots

Lab results & genotype

CMV serostatus
6 of 7 lots
ABO / Rh blood type
5 of 7 lots
HLA class I typing
5 of 7 lots
HLA class II typing
3 of 7 lots

Lifestyle

Tobacco use
7 of 7 lots
Alcohol use
7 of 7 lots
Recreational drug use
7 of 7 lots
Caffeine use
7 of 7 lots

Collection

Collection date
7 of 7 lots
Country of collection
7 of 7 lots

Need a field that isn't listed, such as disease stage or time since diagnosis?

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Need a custom Synovial Fluid cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information